health benefits of microdosing glp 1 Let's talk about “microdosing” GLP-1s — because this trend needs to stop. This idea didn't come from science. It came from inexperienced prescribers who saw patients experiencing side effects at therapeutic doses — The Benefits of GLP-1 Therapy:

Ample evidence shows dysbiosis of gut microbiota in AKI and CKD, such as diabetic kidney disease (DKD), membranous nephropathy (MN), immunoglobulin A nephropathy (IgAN), focal segmental glomerulosclerosis (FSGS), hypertensive nephropathy (HN), and lupus nephritis (LN), as well as renal replacement therapies including peritoneal dialysis (PD), hemodialysis (HD), and kidney transplantation [24, 33-38]

Compounded medications are not FDA-approved and do not undergo safety, effectiveness, or manufacturing review

10.1371/journal.pone.0025269 PLoS One 94 ShelburneJ

It is hypothesized that this peptide sequence might act as a repair signal in cellular communication processes, particularly targeting fibroblasts